Paper35537409
IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy.
Delyon J and 1 other. Cancer Cell, 2022. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy. Papers, record 35537409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35537409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immune Checkpoint Inhibitors | Major topic |
| Neoplasms | Major topic |
| CTLA-4 Antigen | |
| Humans | |
| Immunotherapy | |
| Interleukin-6 | |
| Programmed Cell Death 1 Receptor |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 35537412 | Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. | https://conductscience.org/library/papers/35537412 |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941734 | Genetic and Immunologic Interactions Driving STAT3 Signaling and Macrophage Polarization in Acute Myeloid Leukemia. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941734 | PubMed |
| 42233032 | Research landscape, thematic evolution, and translational insights of immune checkpoint inhibitor-induced colitis: a bibliometric analysis (2006-2025). | Front Immunol | 2026 | https://conductscience.org/library/papers/42233032 | PubMed |
| 41897336 | The Neutrophil-NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897336 | PubMed |
| 41461940 | An ultrasmall core-shell silica nanoparticle improves antitumour immunity and survival by remodelling suppressive melanoma microenvironments. | Nat Nanotechnol | 2026 | https://conductscience.org/library/papers/41461940 | PubMed |
| 41310062 | Immunological factors underlying radiation-induced toxicity in prostate cancer patients: a systematic review. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41310062 | PubMed |
| 40699636 | Exploring Potential Therapeutic Applications of Tazarotene: Gene Regulation Mechanisms and Effects on Melanoma Cell Growth. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699636 | PubMed |
| 39981232 | Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction. | Front Immunol | 2025 | https://conductscience.org/library/papers/39981232 | PubMed |
| 39928524 | Nanoenhanced-Cuproptosis Results From the Synergy of Calcium Overload and GSH Depletion with the Increasing of Intracellular Ca/Mn/Cu Ions. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39928524 | PubMed |
| 39837814 | Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/39837814 | PubMed |
| 39523982 | Tocilizumab for Advanced Non-Small-Cell Lung Cancer With Concomitant Cachexia: An Observational Study. | J Cachexia Sarcopenia Muscle | 2024 | https://conductscience.org/library/papers/39523982 | PubMed |
| 39256296 | Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review. | Cardiovasc Toxicol | 2024 | https://conductscience.org/library/papers/39256296 | PubMed |
| 39015563 | Advancing non-small cell lung cancer treatment: the power of combination immunotherapies. | Front Immunol | 2024 | https://conductscience.org/library/papers/39015563 | PubMed |
| 38689325 | Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis. | J Transl Med | 2024 | https://conductscience.org/library/papers/38689325 | PubMed |
| 38443899 | Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients. | J Transl Med | 2024 | https://conductscience.org/library/papers/38443899 | PubMed |
| 38044322 | Combining immune-checkpoint inhibitors with tocilizumab to treat a lung adenocarcinoma patient with pre-existing polymyalgia rheumatica: A case report. | Thorac Cancer | 2024 | https://conductscience.org/library/papers/38044322 | PubMed |
| 37208766 | Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37208766 | PubMed |
| 36539321 | Treatment of rheumatic adverse events of cancer immunotherapy. | Best Pract Res Clin Rheumatol | 2022 | https://conductscience.org/library/papers/36539321 | PubMed |
| 36198831 | Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases. | Nat Rev Rheumatol | 2022 | https://conductscience.org/library/papers/36198831 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35537409
GET https://conductscience.org/api/papers/v1/35537409/authors